News

Public · Published

Coherent (NYSE:COHR) beats Q3 CY2026 sales expectations, provides optimistic revenue guidance for next quarter

Coherent reported calendar Q3 2026 revenue of $2.37 billion, up 49.9% from a year earlier and above analysts' $2.31 billion estimate. Adjusted earnings were $2.09 per share. For the next quarter, the company forecast revenue of $2.65 billion at the midpoint, with guidance 4.4% above analysts' consensus.

Published:

Updated:

What happened

Coherent reported calendar Q3 2026 revenue of $2.37 billion, up 49.9% from a year earlier and above analysts’ $2.31 billion estimate. Adjusted earnings were $2.09 per share. For the next quarter, the company forecast revenue of $2.65 billion at the midpoint, with guidance 4.4% above analysts’ consensus.

Confirmed

Global impact / market context

Revenue and earnings above estimates, alongside stronger next-quarter guidance, suggest Coherent expects demand to support further sales growth. However, free cash flow—cash left after operating needs and capital spending—was negative $868.2 million, sharply worse than a year earlier, potentially limiting cash available for investment or debt repayment.

Analyst inference

The results pair rapid revenue growth with a large cash outflow, so investors must weigh expected sales against the resources needed to deliver them. The article gives no explanation for the negative free cash flow, making its duration and cause important uncertainties for assessing financial strength.

Analyst inference

What to watch

  1. Compare next quarter’s reported revenue with the $2.65 billion midpoint forecast and assess whether sales growth is sustained beyond the reported 49.9% year-on-year increase. Analyst inference
  2. Track free cash flow in upcoming reports and any explanation of the $868.2 million outflow, since continued cash use could constrain investment or repayment capacity. Analyst inference
  3. Check whether adjusted earnings meet or exceed the next-quarter forecast of $2.38 per share, which was above analysts’ $2.21 consensus estimate. Analyst inference

Evidence